A randomised trial of paclitaxel combined with platinum-based chemotherapy vs conventional platinum-based chemotherapy in the treatment of women with ovarian cancer

Not Applicable

Completed

• Conditions: Ovarian cancer; Cancer; Malignant neoplasm of ovary

• Registration Number: ISRCTN47434271
• Lead Sponsor: Medical Research Council (MRC) (UK)

Brief Summary

2003 Results article in http://www.ncbi.nlm.nih.gov/pubmed/12826431 results

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2000-04-06
• Study Completion: 2002-03-31
• Last Update Posted: 8 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 802

Inclusion Criteria

1. Recurrent epithelial ovarian cancer previously treated with chemotherapy
2. Treatment-free interval of at least 6 months

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Survival time<br> 2. Quality of life<br> 3. Health economics<br>

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration